The tight-skin (TSK) mouse has cutaneous changes similar to those found in the skin of patients with progressive systemic sclerosis (PSS). Previous studies have shown that both have common abnormalities in skin thickness, dry weight, and hydroxyproline content. In this study, glycosaminoglycans (GAGs), major components of the ground substance, were quantitated in skins from TSK mice and compared with age-matched normal mice. Biochemical studies included determinations of hexosamines, uronic acids, and total GAGs by cetylpyridinium chloride precipitation. Dry weights and water-fat content of skin biopsy specimens from TSK mice were also compared with those of normal mice. Hexosamine, uronic acid, total GAGs, and dry weight were increased in TSK mouse skin when compared with normal mouse skin. The water-fat content did not differ significantly. These findings were similar to those known to occur in PSS skin, further suggesting that the TSK mouse might serve as an animal model for the skin changes found in PSS patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/art.1780260512 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Aqueous humor TGFβ and fibrillin-1 in Tsk mice reveal clues to POAG pathogenesis.
Sci Rep
February 2024
Developmental Oncogene Laboratory, California State University Northridge, Northridge, CA, USA.
Article Synopsis
- Aqueous humor and blood levels of TGFβ are found to be higher in both Tsk mice and humans with primary open-angle glaucoma (POAG), suggesting a potential biomarker for the disease.
- Tsk mice, which have a mutation in fibrillin-1, exhibit a POAG phenotype and display significantly elevated levels of TGFβ2 compared to wild-type mice, similar to findings in human POAG subjects.
- This study highlights the presence of different fibrillin-1 isoforms in both Tsk mice and humans with POAG, pointing to a link between TGFβ, fibrillin-1 levels, and glaucoma pathology.
Objective: S100A4 is a DAMP protein. S100A4 is overexpressed in patients with systemic sclerosis (SSc), and levels correlate with organ involvement and disease activity. S100A4 mice are protected from fibrosis.
View Article and Find Full Text PDFIguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression.
Arthritis Res Ther
August 2023
Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China.
Article Synopsis
- EGR1 is a key factor involved in a disease called systemic sclerosis (SSc), which causes thickening of the skin.
- Iguratimod is a new drug that lowers the levels of EGR1, helping to improve conditions in skin cells affected by SSc.
- The study found that iguratimod reduces skin fibrosis and lessens important markers, hinting that lowering EGR1 could be a way to help treat this disease.
spinDrop: a droplet microfluidic platform to maximise single-cell sequencing information content.
Nat Commun
August 2023
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Article Synopsis
- Droplet microfluidic methods have improved the efficiency of single-cell sequencing but face challenges like increased background noise and lower RNA capture rates due to the lack of effective cell enrichment strategies.
- The presented methodology uses fluorescence-activated droplet sorting to isolate droplets containing viable or specific cell types and employs picoinjection for multi-step processes, enhancing gene detection by five times and reducing noise by up to 50%.
- This approach successfully creates a high-quality molecular atlas of mouse brain development and nascent RNA transcription during organogenesis, and can be adapted for various other droplet-based workflows to achieve cost-effective and precise single-cell profiling.
Tsukushi proteoglycan maintains RNA splicing and developmental signaling network in GFAP-expressing subventricular zone neural stem/progenitor cells.
Front Cell Dev Biol
November 2022
Department of Stem Cell Biology, Faculty of Arts and Science, Kyushu University, Fukuoka, Japan.
Tsukushi (TSK) proteoglycan dysfunction leads to hydrocephalus, a condition defined by excessive fluid collection in the ventricles and lateral ventricular enlargement. TSK injections into the LV at birth are effective at rescuing the lateral ventricle (LV). TSK regulates the activation of the Wnt signaling to facilitate the proper expansion of the LV and maintain the fate of the neural stem cell lineage.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!